Clinical Trials Logo

Clinical Trial Summary

This is a phase II, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of velusetrag once a day, compared to placebo, in subjects with CIPO.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05724069
Study type Interventional
Source Alfasigma S.p.A.
Contact
Status Active, not recruiting
Phase Phase 2
Start date December 15, 2021
Completion date April 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04506593 - Indiana University Gastrointestinal Motility Diagnosis Registry
Recruiting NCT04193735 - Pseudo-obstruction Assessment With MRI
Active, not recruiting NCT04118699 - Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial Phase 2
Completed NCT00793247 - Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP) Phase 2